11C-SMW-139

N/A

Report date: 2025/06/11 10:37:54
NME

Base Information

Drug Name11C-SMW-139
Drug Alias Name11C-P2X7 receptor antagonists (KU Leuven/University of Sydney)Carbon-11-SMW-139SMW-139-[11C]11C-SMW-139
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionP2X purinoceptor 7 modulators
TargetsP2X purinoceptor 7
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of SydneyKu Leuven
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A